Literature DB >> 11908774

The transition from viral to autoimmune myocarditis.

S L Hill1, N R Rose.   

Abstract

Myocarditis offers a unique opportunity to study the factors contributing to its transition from a viral infection to an autoimmune disease. In this article, we review recent studies on the role of nitric oxide (NO), gamma interferon (IFN-gamma) and interleukin 12 (IL-12) in the progression from early (viral) to late (autoimmune) phases of myocarditis induced by Coxsackievirus B3 (CB3) in highly susceptible (A.CA) and moderately susceptible (B10.M) mice. NO plays a paradoxical role, being protective in early stages but detrimental later in the course of disease. Treatment with antibody to IFN-gamma reduced early disease, but had little effect on the severity of cardiac lesions at later times. Treatment with recombinant (r) IL-12 significantly reduced the autoimmune cardiac lesions in moderately susceptible B10.M mice, but had no measurable effect in highly susceptible A.CA animals. These studies provide evidence that the profile of inflammatory mediators produced early in the course of viral infection determines the later development of autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11908774     DOI: 10.3109/08916930109007381

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  5 in total

1.  IL-12 is required for differentiation of pathogenic CD8+ T cell effectors that cause myocarditis.

Authors:  Nir Grabie; Michael W Delfs; Jason R Westrich; Victoria A Love; George Stavrakis; Ferhaan Ahmad; Christine E Seidman; Jonathan G Seidman; Andrew H Lichtman
Journal:  J Clin Invest       Date:  2003-03       Impact factor: 14.808

2.  Comparative and correlative assessments of cytokine, complement and antibody patterns in paediatric type 1 diabetes.

Authors:  M Abdel-Latif; A A Abdel-Moneim; M H El-Hefnawy; R G Khalil
Journal:  Clin Exp Immunol       Date:  2017-07-13       Impact factor: 4.330

3.  Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo.

Authors:  Roberta L DeBiasi; Bridget A Robinson; Barbara Sherry; Ron Bouchard; R Dale Brown; Mona Rizeq; Carlin Long; Kenneth L Tyler
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

4.  Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.

Authors:  Kurt Reifenberg; Hans-Anton Lehr; Michael Torzewski; Gisela Steige; Elena Wiese; Ines Küpper; Christoph Becker; Sibylle Ott; Petra Nusser; Ken-Ichi Yamamura; Gerd Rechtsteiner; Tobias Warger; Andrea Pautz; Hartmut Kleinert; Albrecht Schmidt; Burkert Pieske; Philip Wenzel; Thomas Münzel; Jürgen Löhler
Journal:  Am J Pathol       Date:  2007-06-07       Impact factor: 4.307

5.  Maneuvering for advantage: the genetics of mouse susceptibility to virus infection.

Authors:  Seung-Hwan Lee; Ken Dimock; Douglas A Gray; Nicole Beauchemin; Kathryn V Holmes; Majid Belouchi; John Realson; Silvia M Vidal
Journal:  Trends Genet       Date:  2003-08       Impact factor: 11.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.